Journey to new models: Leading change in clinical governance, quality, and equity

  • Leadership


Tuesday 10 September


Session description:

Effective change to revitalize health systems can include a broad range of transformation projects. This session focuses on innovation in models of governance, quality, and equity. Examples include frameworks for integration of clinical and corporate governance, as well as strategic approaches to health promotion and the prevention of hospitalizations.

Chair: Dr Joanne Conroy, President and CEO, Dartmouth Health, USA

  • Leadership


Tuesday 10 September


Chair and Speakers

Dr Joanne Conroy

President and CEO, Dartmouth Health, USA

Joanne Mather Conroy, MD, serves as the President and CEO of Dartmouth Health (DH). As Chief Executive Officer of New Hampshire’s only academic health system, Dr Conroy has overseen significant positive changes – including a dramatic turnaround in the D-HH system’s financial performance and a strategic planning process that will guide the organizations into the future.

Dr Conroy is a committed leader in advancing equity in the workplace. She is a co-founder of “Women of Impact,” a nonpartisan group of 140 female health care leaders representing all sectors of the health care industry across the nation. Dartmouth Health was also one of the founding signatories of the TIME’S UP Healthcare initiative, which aims to increase safety and gender equity in the health care industry.

Prior to her arrival at DH, Dr Conroy served as the Chief Executive Officer of Lahey Hospital and Medical Center in Burlington, MA and as Chief Health Care Officer for the Association of American Medical Colleges in Washington, DC. She has also served as Chief Medical Officer, Vice President of Academic Affairs, and Executive Vice President of the Atlantic Health System based in Florham Park, NJ and as President and Chief Operating Officer for the Morristown Memorial Hospital (now called Morristown Medical Center) in Morristown, NJ.

She received her undergraduate degree in Chemistry from Dartmouth College and her medical degree from MUSC, where she completed her residency in anesthesiology. Dr Conroy is board-certified with the American Board of Anesthesiologists.

Dr Antonio Barra Torres

President-Director, Brazilian Health Regulatory Agency - ANVISA, Brazil

Dr Antonio Barra Torres, the President-Director of the Brazilian Health Regulatory Agency (ANVISA), graduated in Medicine from the Foundation Souza Marques in 1986 and had his residency in Vascular and Endovascular Surgery done at the Marcílio Dias Naval Hospital (HNMD) and MBA in Health Services Administration at the Federal University of Rio de Janeiro in 2012.

In 1987, Dr Barra joined the Brazilian Navy as a Medical Officer. In 2015, he was promoted to the rank of Rear Admiral – the second highest rank in the Medical Corps. Retired from the Navy in February of 2019, he was then approved by the Brazilian Senate to the position of ANVISA’s Director in July of the same year. He was later confirmed as the ANVISA’S President-Director in October 2020.

In March 2023, Dr Barra was appointed as the Second Vice-Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA).

Dr Penelope Dash

Chair, NHS North West London, UK

Penny is Chair of North West London Integrated Care System (ICS) – responsible for improving the health of ~2.5 million people, reducing inequalities in health and ensuring high quality and efficient services within a ~£6bn budget.    The ICS includes all health and care providers in the area (primary care, social care, mental health and community providers, acute hospitals) as well as local government and Universities.

Penny also works with a number of investors and digital health start-ups, is an active angel investor and is co-Chair of the Cambridge Health Network.  She sits on Advisory Boards for Brunel University Medical School, Alzheimer’s Society and the Dementia Research Institute at Imperial.   She is a member of the council of the Institute for Financial Studies (IFS), the NHS Assembly and the London Life Sciences Advisory Board.

Penny spent the last 20 years at McKinsey where she led the healthcare practice across Europe and delivered improvements in health and care in multiple countries.  She worked closely with many leading Pharma & Medical Devices companies and private equity groups.

She was Director of Strategy at the UK Department of Health (2000-2001), Vice Chairman of the King’s Fund (2006-2015) and a Non-Executive Director on the board of the Regulator of Foundation Trusts (2004-2006).

Penny originally trained as a Doctor in Cambridge and London and is a Fellow of the Royal College of Physicians of London. She has an MSc in Public Health Medicine and a MBA from Stanford Business School where she was a Fulbright Scholar.

Dr Ibrahim ElLakany

Chief Quality Officer, Saudi German Hospital, Egypt

Dr Ibrahim El Lakany is a healthcare quality expert with over 20 years of experience in healthcare. He is currently holding the position of Chief Quality Officer in Saudi German Hospital (SGH) – Egypt.

With wide experience in healthcare quality as well as administration, Dr El Lakany held previous positions as Quality Director in Saudi German Hospital – Aseer, and Acting Quality and Patient Safety Manager in Saudi German Hospital – Al Madinah.

During his career, Ibrahim achieved many national and international accreditation and re-accreditation over 18 years in the field – including Joint Commission International (JCI), Canadian Qmentum International, General Authority Healthcare Accreditation and Regulation, and TEMOS (Medical Tourism) Certification ISO 22000/2018 in food safety. In addition, he led many administrative projects including the Civil Defense License renewal in SGH – Aseer in July 2016 and the creation and supervision of new units in SGH – Aseer including a new ER, new ICU, new CCU and CATHLAB, new PICU, and new dialysis units.

Ibrahim was selected by the National Association of Healthcare Quality (NAHQ) as a Poster Presenter for the 38 NAHQ annual conference (Triple Crown of Quality) which was conducted in Louisville, KY, USA from 6 – 9 October 2013.

Ibrahim was a speaker in many symposiums conducted in infection control and quality improvement in SGH – Aseer, SGH – Jeddah, and SGH – Cairo. He was also a speaker in the IHF World Hospital Congress 2023 conducted in Lisbon about value-based healthcare. His project of establishing an integrated quality management model (holistic approach) has been awarded an “honourable award” in the IHF World Hospital Congress in Dubai last 2022.

Prof. Dr Marc Noppen

CEO, Universitair Ziekenhuis Brussel, Belgium

Marc Noppen obtained an MD and PhD in Pulmonology, and practiced for more than 20 years. In 2006, he was appointed as the Chief Executive Officer of a university hospital or the Universitair Ziekenhuis (UZ) Brussel in Brussels, Belgium.

He obtained additional degrees in Farmaco-economy (U Antwerp) and in management and governance (Vlerick Business School Brussels, INSEAD Fontainebleau France). He is an Associate Professor at the Vrije Universiteit Brussel, authored 165 schientific papers, and has an h-index of 39. He is a non-executive board member in various social profit and for profit institutions and companies.